Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rapid Micro Biosystems (RPID) FCF Margin (2020 - 2025)

Rapid Micro Biosystems' FCF Margin history spans 6 years, with the latest figure at 107.55% for Q3 2025.

  • For Q3 2025, FCF Margin fell 782.0% year-over-year to 107.55%; the TTM value through Sep 2025 reached 124.73%, up 4344.0%, while the annual FY2024 figure was 158.5%, 4365.0% up from the prior year.
  • FCF Margin for Q3 2025 was 107.55% at Rapid Micro Biosystems, up from 138.61% in the prior quarter.
  • Across five years, FCF Margin topped out at 99.74% in Q3 2024 and bottomed at 461.79% in Q2 2022.
  • The 5-year median for FCF Margin is 185.25% (2023), against an average of 223.7%.
  • The largest annual shift saw FCF Margin tumbled -26526bps in 2022 before it skyrocketed 27654bps in 2023.
  • A 5-year view of FCF Margin shows it stood at 261.0% in 2021, then skyrocketed by 45bps to 143.74% in 2022, then dropped by -7bps to 153.64% in 2023, then increased by 19bps to 124.0% in 2024, then grew by 13bps to 107.55% in 2025.
  • Per Business Quant, the three most recent readings for RPID's FCF Margin are 107.55% (Q3 2025), 138.61% (Q2 2025), and 130.24% (Q1 2025).